Metabolic differences in colon mucosal cells
|
|
- Randall Skinner
- 5 years ago
- Views:
Transcription
1 Metabolic differences in colon mucosal cells Ross A. McKinnon a Wendy M. Burgess a, Frank J. Gonzalez b and Michael E. McManus c a Department of Clinical Pharmacology, Flinders University, South Australia 5042, Australia, b Laboratory of Molecular Carcinogenesis, National Institutes of Health, Bethesda, MD 20892, USA and c Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Queensland 4067, Australia Summary The colonic expression of cytochromes P450 from the CYPIA, CYP3A and CYP4B subfamilies has been characterized in rabbit and human tissues using RNA blotting, immunoblotting, immunohistochemistry and hybridization histochemistry. These studies demonstrate negligible expression of the CYP1A subfamily in either rabbit or human colon. The CYP3A6 gene is expressed in rabbit colon although at markedly reduced levels relative to liver and small intestine. Whilst at least two CYP3A genes are expressed at the mrna level in human colon tissue from some individuals, no expression was demonstrated in others. Where expression was observed, this expression was continuous throughout the length of the colon. In rabbits, CYP4B1 represents a major colon P450 enzyme, expressed at levels in colon comparable to liver and small intestine. In contrast, the human CYP4B1 gene is expressed at low levels in some individuals. These studies highlight individual differences in the expression of cytochrome P450 enzymes of importance in procarcinogen metabolism. Keywords: Colon mucosal cells; Cytochromes P450; CYP genes Abbreviations: MelQ, 2-amino-3,4-dimethylimidazo[4,5-f]- quinoline; PhIP, 2-amino-l-methyl- 6-phenylimidazo[4,5-b]- pyridine. The nomenclature used to define each of the P450s discussed in this report has been published (Nelson et al., 1993). The gastrointestinal tract represents a major portal of entry for many toxic chemicals and carcinogens. Indeed, Ames et al. have estimated that the vast majority of chemicals to which humans are exposed derive from dietary sources and must therefore traverse the gastrointestinal tract (Ames et al., 1987, Ames, 1989). Given that the vast majority of chemical carcinogens require metabolism before being mutagenic/carcinogenic, it is essential to characterize the xenobiotic metabolizing enzyme systems of all gastrointestinal tissues. Further stimulus for studies of xenobiotic metabolizing enzyme expression in the col- orectal region is provided by the high incidence of malignancies in this region Cytochromes P450 comprise a superfamily of structurally and functionally related heme proteins involved in the phase I metabolism of numerous xenobiotics and endogenous substrates (Nelson et al., 1993). Individual cytochrome P450 isoforms are characterized by diversity in developmental regulation, substrate specificity and tissue distribution. Whilst the majority of cytochrome P450 catalysed oxidations result in diminished toxicity of the parent compound, on occasion this process may generate a more toxic intermediate. Many such metabolites have been implicated in carcinogenesis Substrates for P450 enzymes include a variety of procarcinogens including a group of compounds termed food-derived heterocyclic amines, isolated from cooked meat (Sugimura et al., 1988; Felton et al., 1990) The activation of these compounds to genotoxins involves an obligatory P450 catalysed N- hydroxylation reaction prior to further metabolism by phase II enzymes such as sulfotransferases, Nacetyltransferases and UDP-glucuronosyltransferases. Studies in this laboratory and others have demonstrated that in liver, this obligatory process is primarily catalysed by members of the CYP1A subfamily (McManus et al., 1988a,b, 1989, 1990; Aoyama et al., 1990). In addition, we have recently demonstrated a possible role for CYP3A
2 enzymes in this process in gastrointestinal tissues in the presence of dietary flavonoids (McKinnon et al., 1992). If the colorectal mucosa possesses a significant CYPIA or CYP3A complement, it is possible that activation of foodderived heterocyclic amines to ultimate carcinogens may occur in close proximity to their putative target tissue. Alternatively, the N-hydroxylated metabolites may be formed in liver and transported to the gastrointestinal tract where they may undergo further metabolism by the various phase II enzyme systems. The possible pathways of food-derived heterocyclic amine activation in gastrointestinal tissues are represented schematically in Fig. 1. Given the high incidence of malignancies in the colorectal region, it is prudent to fully characterize the colonic expression of cytochrome P450 enzymes implicated in the activation of procarcinogens such as the food-derived heterocyclic amines and other aromatic amines. The current understanding of the human cytochrome P450 system is based primarily on hepatic studies given its role as the major drug metabolism tissue. In contrast, colorectal expression of individual cytochrome P450 enzymes is poorly characterized. Several studies have reported the expression of a CYP3A protein in human colon using immunoblotting techniques (Peters et al., 1989, 1992; de Waziers et al., 1991). It is unclear from these studies however which CYP3A enzyme(s) is being expressed. In addition, several other studies failed to demonstrate CYP3A protein in human colon (Murray et al., 1988; McKinnon et al., 1992). White et al. (1992) have recently demonstrated the presence of CYP1A protein in human colon microsomes, although several other studies have failed to demonstrate CYP1A expression in colon (de Waziers et al., 1990; McKinnon et al., 1992; Massaad et al., 1992). Given this limited and conflicting data, we have utilized a variety of techniques to further characterize cytochrome P450 expression in colorectal tissues from both rabbits and humans. These studies have focussed on several forms of P450 known to activate procarcinogens. The results demonstrate that whilst the expression of these cytochrome P450 genes in colon is generally minimal, the colon of both humans and rabbits possesses a distinct P450 profile relative to both liver and small intestine. In addition, considerable interindividual heterogeneity is observed in both the level of expression and the individual P450 genes expressed.
3 Expression of cytochromes P450 in rabbit and human colon CYPIA subfamily The CYP1A subfamily comprises two members in both humans and rabbits, designated CYP1A1 and CYP1A2 (Nelson et al., 1993). Using a variety of approaches including purified forms of cytochrome P450, cdna expression systems, hybridization histochemistry, immunochemical techniques and metabolic inhibition studies, we have demonstrated that both members of the CYP1A subfamily are expressed in rabbit and human liver and are primarily responsible for the activation of the food-derived heterocyclic amines (McManus et al., 1988a, 1989, 1990; McKinnon et al., 1991). Utilising a range of techniques including RNA blotting, immunoblotting, immunohistochemistry and hybridization histochemistry, we have been unable to demonstrate CYP1A1 or CYP1A2 expression in any of 18 specimens of human colon. Whilst RNA blotting of human colon mrna samples with CYP1A1 and CYP1A2 RNA probes did not demonstrate the presence of either CYP1A1 and CYP1A2 transcripts, a smaller 2.3- kb transcript was observed in a number of mrna samples. The identity of this transcript is presently unclear although it is unlikely to encode a highly related P450 protein given the lack of protein on immunoblots probed with anti-cyp1a IgG or antisera. In an attempt to gain an insight into the identity of this unknown transcript, a colon cdna library was screened using a CYP1A2 RNA probe which recognizes both CYP1A1 and CYP1A2 sequences. This screening resulted in the isolation of several clones which demonstrated complete sequence similarity with human liver CYPIA1, other than a single conservative base change. As a further indication of CYP1A expression, microsomes were prepared from 4 human colon specimens and used as the activating source for a series of Ames Salmonella tests assessing the activation of the model food-derived heterocyclic amine MelQ. Only one of the four samples of colon microsomes tested exhibited activity towards MelQ. This activity was exceedingly low relative to liver and was completely inhibited by a-naphthoflavone suggesting that in this colon, low level CYP1A expression may be present. Using a similar range of techniques to study the rabbit gastrointestinal tract, no CYP1A expression was observed in colon although CYP1A1 protein was detected on immunoblots of small intestine microsomes. This finding contrasts with that in humans where no CYP1A expression was observed in any gastrointestinal tissue. Collectively the results in both humans and rabbits indicate that the expression of CYP1A enzymes is 30 minimal in colorectal tissue. Based on this data, it therefore appears unlikely that gastrointestinal tissues contribute significantly to the activation of procarcinogens such as the food-derived heterocyclic amines whose activation is primarily dependent on CYP1A enzymes. CYP3A subfamily Stimulus for characterizing the expression of the CYP3A subfamily was generated by the observation that CYP3A enzymes may play a role in the activation of the food-derived heterocyclic amines in the presence of dietary flavonoids (Mc- Kinnon et al., 1992). The adult human CYP3A subfamily comprises at least three genes encoding highly related enzymes designated CYP3A3, CYP3A4 and CYP3A5 (Molowa et al., 1986; Beaune et al., 1986; Gonzalez et al., 1988; Aoyama et al., 1989; Schuetz et al., 1989). Immunoblot and RNA blot analysis of liver samples demonstrates that the CYP3A3 and CYP3A4 isoforms are not distinguishable electrophoretically. One or both of these enzymes represents the major liver species and is expressed in all individuals. A third form designated CYP3A5 has been observed in liver at the protein level in 19 of 66 (29%) subjects (Wrighton et al., 1990). Immunoblot studies in our laboratory have demonstrated the CYP3A5 enzyme in 5 of 22 liver microsomal samples (R.A. McKinnon, W.M. Burgess and M.E. McManus, unpublished results). As outlined earlier, several studies have documented that CYP3A protein is present in human colon although the precise isoforms present remain unresolved (Peters et al., 1989; de Waziers et al., 1991; White et al., 1991). In an attempt to address this problem we have employed a CYP3A4 RNA probe which recognizes all three CYP3A mrna sequences for RNA blotting and hybridization histochemistry analyses of CYP3A mrna in human colon specimens. RNA blot analysis of mrna samples from 11 human colons revealed marked heterogeneity in CYP3A mrna with at least two genes expressed in some colons and none in others (Table 1). A 2.2-kb band representing CYP3A3/3A4 was observed in 5 of the 11 samples. The level of this mrna species was considerably lower in colon specimens rela- tive to both small intestine and liver. A smaller 1.9-kb transcript of variable intensity was observed in 6 of 11 individuals. The lower molecular weight of this mrna is consistent with the bp CYP3A5 cdna as compared with the larger CYP3A3 and CYP3A4 cdnas (Aoyama et al., 1989). This smaller mrna is also observed in liver mrna samples from individuals demonstrating the presence of the CYP3A5 enzyme on immunoblot analysis. It therefore appears that the
4 CYP3A3/3A4 and CYP3A5 genes are both expressed at highly variable levels in human colon. The observation of CYP3A5 mrna in more than half of the colon specimens studied is of particular interest given the low incidence of CYP3A5 expression in liver (approximately 25-30%). In addition, we have been unable to demonstrate CYP3A5 mrna in the small intestine where CYP3A3/3A4 mrna and protein is abundant. The marked heterogeneity in CYP3A mrna patterns between colons does not appear to correlate with gender or the region of colon studied (Table 1). In addition, none of the subjects were being treated with known inducers of CYP3A enzymes. Hybridization histochemistry analysis of multiple segments of colon from single individuals confirmed that in individuals in whom CYP3A genes were expressed, expression was observed throughout the colon, although mrna levels in rectal specimens were generally very low. CYP3A mrna was highest in colon mucosal cells in the non-proliferative compartment. It remains presently unclear if the CYP3A3/3A4 and CYP3A5 mrnas are translated into proteins as we have been unable to demonstrate any CYP3A enzyme on immunoblots of colon microsomes treated with an anti-cyp3a3 IgG known to recognize these enzymes in liver microsomes. The possibility exists that this discrepancy may simply reflect the different sensitivity of the RNA blot and immunoblot techniques, particularly when RNA probes are utilized for RNA blotting. The rabbit CYP3A subfamily presently comprises only a single member designated CYP3A6. Immunoblot analysis of rabbit gastrointestinal microsomes demonstrates the presence of this enzyme in both the small and large intestine (Mc- Kinnon et al., 1992). The level of CYP3A6 decreases from the small to the large intestine, consistent with a decline in total cytochrome P450 levels. CYP4B1 The CYP4B subfamily comprises only a single gene product in rabbits, rats and humans designated CYP4B1 (Nelson et al., 1993). The CYP4B1 enzyme has created particular interest amongst researchers due to its species- and tissuedependent regulation (Robertson et al., 1983; Parandoosh et al., 1987), and capacity to N-hydroxylate the procarcinogen aromatic amine, 2-aminofluorene (Vanderslice et al., 1987). The gastrointestinal expression of CYP4B1 has not been characterized in human or rabbit tissues although analysis of rat mrna samples with a human CYP4B1 cdna demonstrated the presence of the putative CYP4B1 mrna in intestine (Nhamburo et al., 1989). This study did not however specify the segment of intestine analyzed. We therefore employed both blotting and histological analyses to characterize CYP4B1 expression in rabbit and human gastrointestinal tissues. Using both immunoblotting and RNA blotting, we were unable to demonstrate the presence of CYP4B1 expression in any human gastrointestinal tissue. However, employing a human CYP4B1 RNA probe for hybridization histochemistry analyses of routine formalin-fixed, paraffin-embedded biopsy specimens, we were able to detect low levels of CYP4B1 mrna in approximately 50% of human colons. Similar to the findings with the CYP3A subfamily, CYP4B1 mrna was present throughout the length of the colon and was present at highest levels in the non-proliferative cells. This finding demonstrates the enhanced sensitivity of histological techniques which preserve cellular integrity relative to blotting techniques. In contrast to the human situation, CYP4B1 expression was demonstrated in all rabbit gastrointestinal tissues other than stomach. This expression was demonstrated at both the protein and mrna level using both
5 blotting and histological techniques. Of particular interest was the observation that CYP4B1 levels in rabbit colon were comparable to those observed in both the small intestine and liver. This contrasts with the decline seen in total cytochrome P450 levels from small to large intestine and also the parallel decline in CYP1A and CYP3A expression between these tissues. Thus, this particular cytochrome P450 isoform demonstrates a novel pattern of expression in the gastrointestinal tract of both rabbits and humans. Discussion Characterization of cytochrome P450 expression in all gastrointestinal tissues is of considerable importance in understanding the role that metabolism of xenobiotics by the intestinal mucosa plays in pharmacological and toxicological processes. Expression of cytochromes P450 in the colorectal region is of particular interest given the possible role of xenobiotics in the etiology of cancers of this region. The possibility exists that heterogeneity in the expression of cytochromes P450 in colonic mucosa, and the subsequent capacity to activate dietary procarcinogens in close proximity to the putative target tissue, may be a contributing factor to variations in colon cancer incidence. Considering the present data, both in this laboratory and elsewhere, it is clear that cytochromes P450 are expressed in both the rabbit and human gastrointestinal tract. The expression of P450 enzymes in colon is however vastly reduced relative to both hepatic and small intestinal expression, particularly in humans. It appears unlikely therefore that the low level expression of the cytochrome P450 isoforms discussed here plays a significant role in the metabolism of procarcinogens such as the food-derived heterocyclic amines in human colon as represented in Fig. 1. If these compounds do represent human colon carcinogens, it is probable that they are N-hydroxylated by CYP1A enzymes in the liver prior to transport to the colon via the mesenteric artery (Fig. 1). In colon mucosal cells, the N- hydroxylated metabolite may then be further metabolized by phase II enzymes with the resultant formation of covalent adducts. Whilst the studies discussed here suggest a minimal role for members of the CYP1A, CYP3A and CYP4B subfamilies in colonic metabolism, they do demonstrate interesting heterogeneity in the expression of cytochromes P450, both between organs and between individuals. The colon clearly possesses a unique cytochrome P450 complement which differs markedly from the liver and small intestine, both in terms of the isoforms expressed and the level of expression. Further studies involving larger numbers of individuals are clearly required to assess possible mechanisms underlying such heterogeneity. Molecular analysis of the regulation of the CYP3A subfamily in human colon would represent one particularly interesting research area. This subfamily represents an example of clear differences in the regulation of cytochrome P450 genes between the small and large intestines. It may be envisaged that such studies may also provide insights into the mechanisms underlying the polymorphic expression of the CYP3A5 gene observed in human liver. The demonstration of CYP4B1 expression in rabbit colon at levels comparable to liver and small intestine represents a particularly interesting finding. In humans, CYP4B1 was demonstrated in colon by hybridization histochemistry but not in liver or the small intestine. Prior to these studies, assessments of P450 expression in colon have been based primarily on those isoforms of P450 expressed at appreciable levels in liver including members of the CYP1A and CYP3A subfamilies. CYP4B1 represents a constitutive lung enzyme rather than a predominantly hepatic enzyme and thus is a useful model for a "non-hepatic" P450. Given the expression of CYP4B1 in human colon in the absence of hepatic expression, the possibility exists that colonspecific forms of cytochrome P450 also exist. Such isoforms would not necessarily be detected by probes designed purely on the basis of hepatic expression. Clearly, further insights into the role of colon mucosal cells in chemical carcinogenesis will be derived from further studies aimed at characterizing the expression of all identified phase I and phase II xenobiotic metabolizing enzymes in these cells. Further insights into the possible role of colon metabolism in chemical carcinogenesis will also necessitate closer attention to the influence of dietary and environmentally derived chemicals on both the expression and function of these enzymes. The possible importance of such interactions is illustrated by the enhanced ability of CYP3A enzymes to activate food-derived heterocyclic amines in the presence of dietary flavonoids. Clearly the possibility exists for further such interactions given the myriad of chemicals ingested by humans. The role of such interactions in the mucosal metabolism of xenobiotics may play a significant role in the marked susceptibility of this tissue to cancer.
6 References Ames, B.N. Ames, Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ. Mol. Mutagen. 16 (1989), pp. S66 S67. Ames et al., B.N. Ames, E. Magaw and L.S. Gold, Ranking possible carcinogenic hazards. Science 236 (1987), pp Aoyama et al., T. Aoyama, S. Yamano, D.J. Waxman, D.P. Lapenson, U.A. Meyer, V. Fisher, R. Tyndale, T. Inaba, W. Kalow, H.V. Gelboin and F.J. Gonzalez, Cytochrome P-450 hpcn3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J. Biol. Chem. 264 (1989), pp Aoyama et al., T. Aoyama, H.V. Gelboin and F.J. Gonzalez, Mutagenic activation of 2-amino-3- methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Res. 50 (1990), pp Beaune et al., P.H. Beaune, D.R. Umbenhauer, R.W. Bork, R.S. Lloyd and F.P. Guengerich, Isolation and sequence determination of a cdna clone related to human cytochrome P-450 nifedipine oxidase. In: Proc. Natl. Acad. Sci. (U.S.A.) 83 (1986), pp de Waziers et al., I. de Waziers, P.H. Cugnenc, C.S. Yang, J.-P. Leroux and P.H. Beaune, Cytochrome P-450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 253 (1990), pp de Waziers et al., I. de Waziers, P.H. Cugnenc, A. Berger, J.-P. Leroux and P.H. Beaune, Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis 12 (1991), pp Felton and Knize, J.S. Felton and M.G. Knize, Heterocyclic-amine mutagens/carcinogens in foods. In: C.S. Cooper and P.L. Grover, Editors, Chemical Carcinogenesis and Mutagenesis IHandbook of Experimental Pharmacology Vol. 94/1, Springer, Berlin (1990), pp Gonzalez et al., F.J. Gonzalez, B.J. Schmid, M. Umeno, O.W. McBride, J.P. Hardwick, U.A. Meyer, H.V. Gelboin and J.R. Idle, Human P450PCN1: Sequence, chromosome localization, and direct evidence through cdna expression that P450PCN1 is nifedipine oxidase. DNA 7 (1988), pp Massaad et al., L. Massaad, I. de Waziers, V. Ribrag, F. Janot, P.H. Beaune, J. Morizet, A. Gouyett and G.C. Chabot, Comparison of mouse and human colon tumors with regard to phase I and phase II drugmetabolizing enzyme systems. Cancer Res. 52 (1992), pp \ McKinnon et al., R.A. McKinnon, P. de la M. Hall, L.C. Quattrochi, R.H. Tukey and M.E. McManus, Localization of CYP1A1 and CYP1A2 mrna in normal human liver and hepatocellular carcinoma by in situ hybridization. Hepatology 14 (1991), pp McKinnon et al., R.A. McKinnon, W.M. Burgess, P. de la M. Hall, Z. Abdul-Aziz and M.E. McManus, Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res. 52 (1992), pp. 2108s 2113s. McManus et al., 1988a. M.E. McManus, W. Burgess, E.G. Snyderwine and I. Stupans, Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3- methylimidazo[4,5-f]quinolone. Cancer Res. 48 (1988a), pp McManus et al., 1988b. M.E. McManus, W. Burgess, I. Stupans, K.J. Trainor, M. Fenech, R.A. Robson, A.A. Morley and E.G. Synderwine, Activation of the food-derived mutagen 2-amino-3-methylimidazo[4,5- f]quinoline by human liver microsomes. Mutation Res. 204 (1988b), pp McManus et al., M.E. McManus, J.S. Felton, M.G. Knize, W.M. Burgess, S. Roberts-Thomson, S.M. Pond, I. Stupans and M.E. Veronese, Activation of the food-derived mutagen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P Carcinogenesis 10 (1989), pp McManus et al., M.E. McManus, W.M. Burgess, M.E. Veronese, A. Huggett, L.C. Quattrochi and R.H. Tukey, Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocylic amine mutagens by human cytochromes P-450. Cancer Res. 50 (1990), pp Molowa et al., D.T. Molowa, E.G. Schuetz, S.A. Wrighton, P.B. Watkins, P. Kremers, G. Mendez-Picon, G.A. Parker and P.S. Guzelian, Complete cdna sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. In: Proc. Natl. Acad. Sci. (U.S.A.) 83 (1986), pp Murray et al., G.I. Murray, T.S. Barnes, H.F. Sewell, S.W. Ewen, W.T. Melvin and M.D. Burke, The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and
7 extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br. J. Clin. Pharmacol. 25 (1988), pp Nelson et al., D.R. Nelson, T. Kamataki, D.J. Waxman, F.P. Guengerich, R.W. Estabrook, R. Feyereisen, F.J. Gonzalez, M.J. Coon, I.C. Gunsalus, O. Gotoh, K. Okuda and D.W. Nebert, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12 (1993), pp Nhamburo et al., P.T. Nhamburo, F.J. Gonzalez, O.W. McBride, H.V. Gelboin and S. Kimura, Identification of a new P450 expressed in human lung: complete cdna sequence, cdna-directed expression, and chromosome mapping. Biochemistry 28 (1989), pp Parandoosh et al., Z. Parandoosh, V.S. Fujita, M.J. Coon and R.M. Philpot, Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver, Comparisons of structure and inducibility. Drug. Metab. Dispos. 15 (1987), pp Peters and Kremers, W.H.M. Peters and P.G. Kremers, Cytochromes P-450 in the intestinal mucosa of man. Biochem. Pharmacol. 38 (1989), pp Peters et al., W.H.M. Peters, C.E.W. Boon, H.M.J. Roelofs, T. Wobbes, F.M. Nagengast and P.G. Kremers, Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology 103 (1992), pp Robertson et al., I.G.C. Robertson, C. Serabjit-Singh, J.E. Croft and R.M. Philpot, The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Mol. Pharmacol. 24 (1983), pp Schuetz et al., J.D. Schuetz, D.T. Molowa and P.S. Guzelian, Characterization of a cdna encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch. Biochem. Biophys. 274 (1989), pp Sugimura et al., T. Sugimura, S. Sato and K. Wakabayashi, Mutagens/carcinogens in pyrolysates of amino acids and proteins in cooked foodsl heterocyclic aromatic amines. In: Y.T. Woo, D.Y. Lai, J.C. Arcos and M.F. Argus, Editors, Chemical Induction of Cancer, Structural Bases and Biological Mechanisms, Academic Press, New York (1988), pp Vanderslice et al., R.R. Vanderslice, B.A. Domin, G.T. Carver and R.M. Philpot, Species-dependent expression and induction of homologues of rabbit cytochrome P-450 isozyme 5 in liver and lung. Mol. Pharmacol. 31 (1987), pp White et al., T.B. White, D.K. Hammond, H. Vasquez and H.W. Strobel, Expression of two cytochromes P450 involved in carcinogen activation in a human cell line. Mol. Cell. Biochem. 102 (1991), pp
P450I I E 1 Gene : Dra I. Human Cytochrome Polymorphism and
Tohoku J. Exp. Med., 1992, 168, 113-117 Human Cytochrome Polymorphism and P450I I E 1 Gene : Dra I Susceptibility to Cancer FUMIYUKI VEMATSUHIDEAKI KIKUCHI*, MASAKICHI MOTOMIYA j', TATSUYA ABE j', CHIKASHI
More informationChemical Carcinogenesis November
Chemical Carcinogenesis November 18 2014 Cancer Incidence and Death rates by Geography Epidemiological studies of cancer incidence indicate: 1. The incidence rates for specific organ tumors varies among
More informationXenobiotic metabolising enzyme expression in
1234 Department of Pathology J A McKay SW B Ewen G I Murray Department of Biomedical Sciences R J Weaver M D Burke Department of Molecular and Cell Biology, University of Aberdeen, Aberdeen W T Melvin
More informationChemical Carcinogenesis November
Chemical Carcinogenesis November 17 2016 Cancer Incidence and Death rates by Geography Epidemiological studies of cancer incidence indicate: 1. The incidence rates for specific organ tumors varies among
More informationChapter 4. Drug Biotransformation
Chapter 4 Drug Biotransformation Drug Biotransformation 1 Why is drug biotransformation necessary 2 The role of biotransformation in drug disposition 3 Where do drug biotransformation occur 4 The enzymes
More informationHeterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol
Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol The N-demethylation of erythromycin and 6P-hydroxylation of cortisol are both functions of the glucocorticoid-inducible CYP3A in human
More informationToxicity profiles of heterocyclic aromatic amines Bettina Seeger and Pablo Steinberg
Toxicity profiles of heterocyclic aromatic amines Bettina Seeger and Pablo Steinberg Institute for Food Toxicology and Analytical Chemistry Mutagenic compounds present in strongly heated meat polycyclic
More informationBIOMARKERS AND TOXICITY MECHANISMS 07 Mechanisms Metabolism & Detoxification. Luděk Bláha, PřF MU, RECETOX
BIOMARKERS AND TOXICITY MECHANISMS 07 Mechanisms Metabolism & Detoxification Luděk Bláha, PřF MU, RECETOX www.recetox.cz Metabolism and detoxification Chemicals enter body... mostly via food Pass directly
More informationBMC Gastroenterology. Open Access. Abstract
BMC Gastroenterology BioMed Central Research article Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma Ina Bergheim* 1,2, Christiane Bode
More informationCHLOROPHYLL WATER. Deodorizes the Body... Cleansing / Scavenging Cancerous Free Radicals... CHLOROPHYLL / CHLOROPHYLLIN RESEARCH SUMMARY
CHLOROPHYLL WATER CHLOROPHYLL / CHLOROPHYLLIN RESEARCH SUMMARY Deodorizes the Body........................................................... Biological Activities of Chlorophyll Derivatives, N.J. Med
More informationAssociation between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis
Association between the CYP1A1 polymorphisms and hepatocellular carcinoma: a meta-analysis B.W. Yu 1 *, L.Q. Zhang 1 *, X.L. Teng 1, Y. Zhang 1, L.B. Zou 2 and H.Y. Ying 3 l Department of Clinical Laboratory,
More informationRegulation of P450. b. competitive-inhibitor but not substrate. c. non-competitive inhibition. 2. Covalent binding to heme or protein
10. Inhibition of P450 Regulation of P450 a. competitive-2 chemicals metabolized by same isoform b. competitive-inhibitor but not substrate c. non-competitive inhibition 11. Induction of P450 1. Non-covalent
More informationHepatocarcinogenesis: chemical models
Hepatocarcinogenesis: chemical models Introduction Earliest observations that human exposure to certain chemicals is related to an increased incidence of cancer John Hill 1761 Nasal cancer in snuff users
More informationExpression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD
Eur Respir J 2001; 18: Suppl. 32, 122s 126s Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0904-1850 ISBN 1-904097-01-4 SELECTED REPORT Expression
More informationMODULE No.26: Drug Metabolism
SUBJECT Paper No. and Title Module No. and Title Module Tag PAPER No. 9: Drugs of Abuse MODULE No. 26: Drug Metabolism FSC_P9_M26 TABLE OF CONTENTS 1. Learning Outcomes 2. Introduction 3. Sites of Drug
More informationChapter 9. Biotransformation
Chapter 9 Biotransformation Biotransformation The term biotransformation is the sum of all chemical processes of the body that modify endogenous or exogenous chemicals. Focus areas of toxicokinetics: Biotransformation
More informationBiotransformation enzymes in human intestine:
48 Biotransformation enzymes in human intestine: critical low levels in the colon? Gut, 1991,32,48-412 W H M Peters, L Kock, F M Nagengast, P G Kremers Division of Gastrointestinal and Liver Diseases,
More informationThe Role of CCR9 and Melanoma Metastasis to Small Intestine. Farin Amersi, MD Samuel Oschin Comprehensive Cancer Center Cedar Sinai Medical Center
The Role of CCR9 and Melanoma Metastasis to Small Intestine Farin Amersi, MD Samuel Oschin Comprehensive Cancer Center Cedar Sinai Medical Center BACKGROUND Melanoma is the fifth most common cancer. Estimated
More informationB. Incorrect! Compounds are made more polar, to increase their excretion.
Pharmacology - Problem Drill 04: Biotransformation Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What is biotransformation?
More informationDevelopment of important genes during breast carcinogenesis
Nagoya Med. J., 107 Development of important genes during breast carcinogenesis AYA NAIKI-ITO Department of experimental pathology and tumor biology Nagoya City University Graduate School of Medical Sciences
More informationEnvironmental Management & Pollution Environmental and Chemical Carcinogenesis
Environmental Management & Pollution Environmental and Chemical Carcinogenesis 8.1 Abstract People are continuously exposed exogenously to varying amounts of chemicals that have been shown to have carcinogenic
More information2. List routes of exposure in the order of most rapid response.
Practice Test questions: 1. What are the two areas of toxicology that a regulatory toxicologist must integrate in order to determine the "safety" of any chemical? 2. List routes of exposure in the order
More informationINVOLVEMENT OF CYP2E1 AS A LOW-AFFINITY ENZYME IN PHENACETIN O-DEETHYLATION IN HUMAN LIVER MICROSOMES
0090-9556/99/2708-0860 865$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 8 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. INVOLVEMENT OF
More informationHelping the liver to detoxify mycotoxins
Helping the liver to detoxify mycotoxins Mycotoxin strategies have so far focused on binding compounds or detoxifying the compounds by feed additives. Animals however, can also detoxify mycotoxins themselves
More informationKing s Research Portal
King s Research Portal DOI: 10.1002/ijc.29836 Document Version Publisher's PDF, also known as Version of record Link to publication record in King's Research Portal Citation for published version (APA):
More informationThe importance of pharmacogenetics in the treatment of epilepsy
The importance of pharmacogenetics in the treatment of epilepsy Öner Süzer and Esat Eşkazan İstanbul University, Cerrahpaşa Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology Introduction
More informationGenetics and Genomics: Influence on Individualization of Medication Regimes
Genetics and Genomics: Influence on Individualization of Medication Regimes Joseph S Bertino Jr., Pharm.D., FCCP Schenectady, NY USA Goals and Objectives To discuss pharmacogenetics and pharmacogenomics
More informationREGULATION OF CYTOCHROME P4501A1 EXPRESSION IN RAT SMALL INTESTINE
0090-9556/97/2501-0021 26$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 25, No. 1 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. REGULATION OF CYTOCHROME
More informationMetabolic Changes of Drugs and Related Organic Compounds
Metabolic Changes of Drugs and Related Organic Compounds 3 rd stage/ 1 st course Lecture 3 Shokhan J. Hamid 2 Metabolism plays a central role in the elimination of drugs and other foreign compounds from
More informationComparison of urinary 6-13-cortisol and the
Comparison of urinary 6-13-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity The production of "CO2 in the breath from an intravenous dose of ["C-N-methyl]erythromycin
More informationOpinion on. Classification of Musk ketone
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER
More informationConstitutive Regulation of P450s by Endocrine Factors
References: Constitutive Regulation of P450s by Endocrine Factors Meyer UA. Endo-xenobiotic crosstalk and the regulation of cytochromes P450. Drug Metab Rev 39:639-46, 2007. Waxman DJ and O Connor C. Growth
More informationPHYSIOLOGY AND MAINTENANCE Vol. II Biotransformation of Xenobiotics and Hormones - Osmo Hanninen BIOTRANSFORMATION OF XENOBIOTICS AND HORMONES
BIOTRANSFORMATION OF XENOBIOTICS AND HORMONES Osmo Hänninen Department of Physiology, University of Kuopio, Finland Keywords: foreign compounds, xenobiotics, bioactivation, detoxification, oxidation, cytochrome
More informationEffect of Septilin A Herbal Preparation on Pharmacokinetics of Carbamazepine in Rabbits
[Indian Journal of Physiology and Pharmacology (1998): (42), 4, 527] Effect of Septilin A Herbal Preparation on Pharmacokinetics of Carbamazepine in Rabbits Garg, S.K., Afm. S. Islam and Naresh Kumar Department
More informationChapter 6: Estrogen Metabolism by Conjugation
Chapter 6: Estrogen Metabolism by Conjugation Rebecca Raftogianis, Cyrus Creveling, Richard Weinshilboum, Judith Weisz The involvement of estrogens in carcinogenic processes within estrogen-responsive
More informationdna oestrogen GENOTYPE REPORT Patient Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported:
dna oestrogen GENOTYPE REPORT Patient Name: Date of Birth: Sample Number: Referring Practitioner: Date Reported: BACKGROUND TO THE ANALYSIS The importance of both oestrogen and progesterone in breast cancer
More informationThe Hepatic Reductase Null (HRN ) and Reductase Conditional Null. (RCN) mouse models as suitable tools to study metabolism, toxicity and
Electronic Supplementary Material (ESI) for Toxicology Research. This journal is The Royal Society of Chemistry 2014 1 The Hepatic Reductase Null (HRN ) and Reductase Conditional Null (RCN) mouse models
More informationSmoke Like a Man, Survive Like a Woman
Smoke Like a Man, Survive Like a Woman Sex Specific Differences in Lung Cancer Pulmonary Grand Rounds Philippe R. Montgrain, M.D. May 1, 2008 Objectives 1. Review how lung cancer differs in men and women.
More informationComparison of Mouse and Human Colon Tumors with Regard to Phase I and Phase II Drug-metabolizing Enzyme Systems 1
[CANCER RESEARCH 52, 6567-6575, December 1, 1992] Comparison of Mouse and Human Colon Tumors with Regard to Phase I and Phase II Drug-metabolizing Enzyme Systems 1 Liliane Massaad, 2 Isabelle de Waziers,
More informationChemically Reactive Drug Metabolites in Drug Discovery and Development Detection, Evaluation, and Risk Assessment
Chemically Reactive Drug Metabolites in Drug Discovery and Development Detection, Evaluation, and Risk Assessment Pacific Northwest Bio Meeting Seattle, WA, August 14, 2012 Thomas A. Baillie, PhD, DSc
More informationof a second P related protein was
Differential Regulation of Liver P-450111 Cytochromes in Choline-deficient Rats: Implications for the Erythromycin Breath Test as a Parameter of Liver Function Progressive liver fibrosis in rats develops
More informationGlutathione Regulation
The Virtual Free Radical School Glutathione Regulation Dale A. Dickinson 1, Henry Jay Forman 1 and Shelly C. Lu 2 1 University of California, Merced, School of Natural Sciences, P.O. Box 2039, Merced,
More informationTitle: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study
Author's response to reviews Title: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study Authors: Bernd Frank (b.frank@dkfz.de) Heiko Müller (h.mueller@dkfz.de) Melanie
More informationMechanism of Detoxification
Mechanism of Detoxification Prof.Dr. Hedef Dhafir El-Yassin 1 Objectives: 1. To list the detoxification pathways 2. To describe detoxification pathways and phases in the liver, 2 3 4 o Xenobiotics are
More informationLarge interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity
et al. DOI:1.146/j.1365-2125.3.197.x British Journal of Clinical Pharmacology Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity
More informationInternational Agency for Research on Cancer (IARC) - Summaries & Evaluations
International Agency for Research on Cancer (IARC) - Summaries & Evaluations AFLATOXINS Naturally Occurring Aflatoxins (Group1) Aflatoxin M1 (Group 2B) For definition of Groups, see Preamble Evaluation.
More informationCysteine Peptide Scientific Review, Dr. S. Dudek, DMV International
Cysteine Peptide Scientific Review, Dr. S. Dudek, DMV International Ethanol and Glutathione Reduced glutathione plays a critical role in cellular detoxification processes including the metabolism of peroxides,
More informationCytochrome P450 Suppression in Human Hepatocyte Cultures by Small and Large Molecules. George Zhang, Ph.D. April 18, 2012
Cytochrome P450 Suppression in Human Hepatocyte Cultures by Small and Large Molecules George Zhang, Ph.D. April 18, 2012 Presentation Overview Regulatory guidance Brief review on drug-drug (Disease) interactions
More informationIt the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.
It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues. Primarily depends on: 1.Regional blood flow. 2.Capillary permeability. 3.Protein
More informationDifferential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes
Differential selectivity of cytochrome P4 inhibitors against probe substrates in human and rat liver microsomes Victoria A. Eagling, John F. Tjia & David J. Back Department of Pharmacology & Therapeutics,
More informationR. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam 3, V.E. Steele 4, S. De Flora 2
INCON / 10 ICMAA, Guarujà, Brazil, September 26-29, 2010 MECHANISMS OF INHIBITION OF CIGARETTE SMOKE GENOTOXICITY AND CARCINOGENICITY 1 2 3 4 R. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam
More informationCytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and primates. Universal oxygenases (oxygen-
Cytochrome P 450 Biochemistry Department Cytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and primates. Universal oxygenases (oxygen-utilizing
More informationTIME COURSE EFFECT OF DIETARY EXPOSURE FROM CRUCIFEROUS AND APIACEOUS VEGETABLES ON RAT HEPATIC CYP1A1, CYP1A2, AND SULT1A1 ENZYMES
TIME COURSE EFFECT OF DIETARY EXPOSURE FROM CRUCIFEROUS AND APIACEOUS VEGETABLES ON RAT HEPATIC CYP1A1, CYP1A2, AND SULT1A1 ENZYMES A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationCharacterization of the Cytochrome P450 CYP234: Expression in Rat Small Intestine and Role in Retinoic Acid Biotransformation from Retinal *
Characterization of the Cytochrome P450 CYP234: Expression in Rat Small Intestine and Role in Retinoic Acid Biotransformation from Retinal * By: Qing-Yu Zhang, Gregory Raner, Xinxin Ding, Deborah Dunbar,
More informationTSUTOMU SHIMADA, YOSHIMITSU ODA, ELIZABETH M. J. GILLAM, F. PETER GUENGERICH, AND KIYOSHI INOUE
0090-9556/01/2909-1176 1182$3.00 DRUG METABOLISM AND DISPOSITION Vol. 29, No. 9 Copyright 2001 by The American Society for Pharmacology and Experimental Therapeutics 403/923026 DMD 29:1176 1182, 2001 Printed
More information[GANN, 59, ; October, 1968] CHANGES IN ALDOLASE ISOZYME PATTERNS OF HUMAN CANCEROUS TISSUES
[GANN, 59, 415-419; October, 1968] UDC 616-006-092.18 CHANGES IN ALDOLASE ISOZYME PATTERNS OF HUMAN CANCEROUS TISSUES Kiyoshi TSUNEMATSU, Shin-ichi YOKOTA, and Tadao SHIRAISHI (Third Department of Internal
More informationDisparities of conjugating protective enzyme activities in the colon of patients with adenomas and carcinomas
Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v19.i36.6020 World J Gastroenterol 2013 September 28; 19(36): 6020-6025 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2013
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationKey words: superoxide dismutase, colo-rectal cancer, immunohistochemistry
Key words: superoxide dismutase, colo-rectal cancer, immunohistochemistry Table I Immunohistochemical stainins of SOD in the colorectal cancer Histological diagnosis normal mucosa # cancer well diff. moderate
More informationDavid Lewin MD Medical University of South Carolina
Top 10 Advances in GI Pathology David Lewin MD Medical University of South Carolina No Disclosures Overview Top Articles/ presentations in the following areas Imaging (3) Molecular (2) Therapeutics (3)
More informationProcessed meats and cancer Mariana C. Stern, PhD Associate Professor of Preventive Medicine & Urology USC Norris Comprehensive Cancer Center
Processed meats and cancer Mariana C. Stern, PhD Associate Professor of Preventive Medicine & Urology USC Norris Comprehensive Cancer Center July 29, 2016 International Conference on Nutrition in Medicine
More informationCytochrome P450 Drug Interaction Table Flockhart Table
Cytochrome P450 Drug Interaction Table Flockhart Table The table contains lists of drugs in columns under the designation of specific cytochrome P450 isoforms. CYTOCHROME P450 DRUG INTERACTION TABLE A
More informationCytokrom P450 (CYP) Hepatic Drug Metabolism. Medicines in plasma. Plasma concentration of a medicine. Eva Brittebo Dept Pharmaceutical Biosciences
Hepatic Drug Metabolism Eva Brittebo Dept Pharmaceutical Biosciences Background Cytochrome P450 (CYP) Liver metabolism Liver toxicity Inhibition and induction Polymorphism 15-05-13 2 Plasma concentration
More informationEstrogen Report GENOTYPE REPORT OPTIMAL HEALTH FOR LIFE. John Doe NAME DATE OF BIRTH 7/31/1999 REFFERRING PRACTITIONER. Dr. Exercise/Diet specialist
Estrogen Report OPTIMAL HEALTH FOR LIFE NAME John Doe DATE OF BIRTH 7/31/1999 GENOTYPE REPORT REFFERRING PRACTITIONER DATE REPORTED ACCESSION NUMBER Dr. Exercise/Diet specialist 2/27/2018 8:42:57 AM 000000000001
More information3-D human skin models appropriate test systems for toxicology testing?
3-D human skin models appropriate test systems for toxicology testing? Veronika Blatz BASF SE Experimental Toxicology and Ecology Germany 10.10.13 2 nd Skin Metabolism Meeting, Valbonne, 2013 1 Cutaneous
More informationCHAPTER 7 Concluding remarks and implications for further research
CONCLUDING REMARKS AND IMPLICATIONS FOR FURTHER RESEARCH CHAPTER 7 Concluding remarks and implications for further research 111 CHAPTER 7 Molecular staging of large sessile rectal tumors In this thesis,
More informationENHANCEMENT OF CYTOCHROME P-450 3A4 CATALYTIC ACTIVITIES BY CYTOCHROME b 5 IN BACTERIAL MEMBRANES
0090-9556/99/2709-0999 1004$02.00/0 DRUG METABOLISM AND DISPOSITION Vol. 27, No. 9 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. ENHANCEMENT OF
More informationProtection o f Ethanol-mediated Acetaminophen Hepatotoxicity by Triacetyloleandomycin, a Specific Inhibitor or CYP3A*
ANNALS O F CLIN IC A L AND LABORATORY SCIENCE, Vol. 27, No. 1 Copyright 1997, Institute for Clinical Science, Inc. Protection o f Ethanol-mediated Acetaminophen Hepatotoxicity by Triacetyloleandomycin,
More informationObjectives Making CYP450, Drug Interactions, & Pharmacogenetics Easy
Objectives Making, Drug Interactions, & Pharmacogenetics Easy Anthony J. Busti, MD, PharmD, FNLA, FAHA Describe the differences between phase I and phase II metabolic pathways. Identify the most common
More informationIncreasing Trend in the Incidence of Colorectal Cancer in Japan
Cancer Increasing Trend in the Incidence of Colorectal Cancer in Japan JMAJ 46(6): 251 256, 2003 Susumu KODAIRA Professor, Department of Surgery, Teikyo University School of Medicine Abstract: Malignant
More informationDetection of Food Mutagens in Processed Meat
Journal of Food and Nutrition Research, 2014, Vol. 2, No. 9, 556-560 Available online at http://pubs.sciepub.com/jfnr/2/9/5 Science and Education Publishing DOI:10.12691/jfnr-2-9-5 Detection of Food Mutagens
More informationClick to edit Master title style
A Short Course in Pharmacokinetics Chris Town Research Pharmacokinetics Outline Pharmacokinetics - Definition Ideal Pharmacokinetic Parameters of a New Drug How do we optimize PK for new compounds Why
More informationDOWNLOAD OR READ : CYTOCHROME P450 STRUCTURE MECHANISM AND BIOCHEMISTRY 2ND EDITION PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : CYTOCHROME P450 STRUCTURE MECHANISM AND BIOCHEMISTRY 2ND EDITION PDF EBOOK EPUB MOBI Page 1 Page 2 cytochrome p450 structure mechanism and biochemistry 2nd edition cytochrome p450 structure
More informationReal-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver
TOXICOLOGICAL SCIENCES 71, 11 19 (2003) Copyright 2003 by the Society of Toxicology Real-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver Thomas K. H. Chang, 1 Jie Chen,
More informationWelcome. to your dna osetrogen report. Welcome to your dna oestrogen report
optimal health for life Welcome to your dna osetrogen report Date of Birth: Date Reported: Sample Number: Referring Practitioner: Welcome to your dna oestrogen report From your buccal swab sample we have
More informationP450 CYCLE. All P450s follow the same catalytic cycle of;
P450 CYCLE All P450s follow the same catalytic cycle of; 1. Initial substrate binding 2. First electron reduction 3. Oxygen binding 4. Second electron transfer 5 and 6. Proton transfer/dioxygen cleavage
More informationWelcome to your dna oestrogen report
optimal health for life Welcome Report Sample to your dna oestrogen report Date of Birth: 08 Jan 1990 Date Reported: 31 May 2018 05:33 Sample Number: DNA000000ZA Referring Practitioner: Doctor X Welcome
More informationHerlyn Lab - Monoclonal Antibodies
Herlyn Lab - Monoclonal Antibodies GI Tract tumors I. Lewis and related antigens 1. 1116-NS-19-9 (CO 19-9), IgG1, Sialylated Le a Koprowski et al. 1979 2. 129-2-C3-9-11 (CO 29.11), IgG1, Sialylated Le
More informationMolecular Regulation of Cytochrome P4501A1 Induction by Hyperoxia in Human Pulmonary Cells
Molecular Regulation of Cytochrome P4501A1 Induction by Hyperoxia in Human Pulmonary Cells Sudeepta K. Basu, MD Neonatology Fellow, Baylor College of Medicine Attending, Children s National Health System
More informationHIROSHI YAMAZAKI, KIYOSHI INOUE, PETER M. SHAW, WILLIAM J. CHECOVICH, F. PETER GUENGERICH and TSUTOMU SHIMADA
0022-3565/97/2832-0434$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 283, No. 2 Copyright 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationBIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES
Vol. 43, No. 4, November 1997 Pages 839-846 DIFFERENTIAL INHIBITION OF AFLATOXIN B1 OXIDATION BY GESTODENE ACTION ON HUMAN LIVER MICROSOMES Bok Ryang Kim,* Hyun Sook Oh,** and Dong-Hyun Kim ~t'l *Department
More informationSpecies and strain differences in drug metabolism in liver and intestine Martignoni, Marcella
University of Groningen Species and strain differences in drug metabolism in liver and intestine Martignoni, Marcella IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF)
More informationTissue-specific Expression and
Metabolic Activation of Toxins: Tissue-specific Expression and Metabolism in Target Organs Olavi Pelkonen and Hannu Raunio Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland Cytochrome
More informationHLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER
HLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER Megan Garrity, S. Breanndan Moore, M.D., William Sandborn, M.D., Vernon Pankratz, Ph.D.,
More informationmicrorna Presented for: Presented by: Date:
microrna Presented for: Presented by: Date: 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions
More informationMaterials and Methods , The two-hybrid principle.
The enzymatic activity of an unknown protein which cleaves the phosphodiester bond between the tyrosine residue of a viral protein and the 5 terminus of the picornavirus RNA Introduction Every day there
More informationCATALYTIC SPECIFICITY OF CYP2D ISOFORMS IN RAT AND HUMAN
0090-9556/02/3009-970 976$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 9 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 696/1004051 DMD 30:970 976, 2002 Printed
More informationDoctor of Philosophy
Regulation of Gene Expression of the 25-Hydroxyvitamin D la-hydroxylase (CYP27BI) Promoter: Study of A Transgenic Mouse Model Ivanka Hendrix School of Molecular and Biomedical Science The University of
More informationLin Cui, 1, 4 Satoru Takahashi, 1 Mariko Tada, 3 Koji Kato, 1 Yasuyuki Yamada, 2 Kenjiro Kohri 2 and Tomoyuki Shirai 1
Jpn. J. Cancer Res. 91, 52 58, January 2000 Immunohistochemical Detection of Carcinogen-DNA Adducts in Normal Human Prostate Tissues Transplanted into the Subcutis of Athymic Nude Mice: Results with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
More informationFUNCTIONAL CHARACTERIZATION OF CYTOCHROME P450 2B6 ALLELIC VARIANTS
0090-9556/03/3104-398 403$7.00 DRUG METABOLISM AND DISPOSITION Vol. 31, No. 4 Copyright 2003 by The American Society for Pharmacology and Experimental Therapeutics 973/1050100 DMD 31:398 403, 2003 Printed
More informationGenomics and proteomics offers new hopes towards a personalized approach to lung cancer prevention and treatment
Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.6 No.3, Issue of December 15, 2003 2003 by Pontificia Universidad Católica de Valparaíso -- Chile BIOTECHNOLOGY ISSUES FOR DEVELOPING COUNTRIES Genomics
More informationgenomics for systems biology / ISB2020 RNA sequencing (RNA-seq)
RNA sequencing (RNA-seq) Module Outline MO 13-Mar-2017 RNA sequencing: Introduction 1 WE 15-Mar-2017 RNA sequencing: Introduction 2 MO 20-Mar-2017 Paper: PMID 25954002: Human genomics. The human transcriptome
More informationKIMBERLEY J. WOODCROFT and RAYMOND F. NOVAK
0022-3565/99/2892-1121$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 289, No. 2 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationTypes of Electrophilic Carcinogenic Intermediates
Types of Electrophilic Carcinogenic Intermediates Procarcinogens Reactive intermediates Enzymes involved in control Aromatic hydrocarbons Epoxides Cytochromes P450 Glutathione S-transferases Epoxide hydrolases
More informationDrug Metabolism Phase 2 conjugation reactions. Medicinal chemistry 3 rd stage
Drug Metabolism Phase 2 conjugation reactions Medicinal chemistry 3 rd stage 1 Phase II or Conjugation reactions 1. Glucuronic acid conjugation 2. Sulfate conjugation 3. Glycine and Glutamine conjugation
More informationTest Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar
Link full download: http://testbankair.com/download/test-bank-for-robbins-cotran-pathologic-basis-of-disease-9th-edition-bykumar-abbas-and-aster Test Bank for Robbins and Cotran Pathologic Basis of Disease
More informationDetermination of 10 Heterocyclic Aromatic Amines in Roast Meat by HPLC
Advanced Materials Research Online: 2013-09-10 ISSN: 1662-8985, Vols. 807-809, pp 369-372 doi:10.4028/www.scientific.net/amr.807-809.369 2013 Trans Tech Publications, Switzerland Determination of 10 Heterocyclic
More informationMolecular docking of retinoic acid with cytochrome P450 isoforms CYP1A1, 1A2 and 1B1 a potential drug target against carcinogen benzo(a)pyrene
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationMETABOLISM OF ( )- AND ( )-LIMONENES TO RESPECTIVE CARVEOLS AND PERILLYL ALCOHOLS BY CYP2C9 AND CYP2C19 IN HUMAN LIVER MICROSOMES
0090-9556/02/3005-602 607$7.00 DRUG METABOLISM AND DISPOSITION Vol. 30, No. 5 Copyright 2002 by The American Society for Pharmacology and Experimental Therapeutics 641/981193 DMD 30:602 607, 2002 Printed
More informationDual-Domain Oxidase 2 (Duox2): A Non-phagocytic NADPH Oxidase Homologue
Dual-Domain Oxidase 2 (Duox2): A Non-phagocytic NADP Oxidase omologue Joshua Eastvold University of Iowa Roy J. and Lucille A. Carver College of Medicine Anatomy and Cell Biology Medical Science Training
More information